More than 500 million people around the world live with osteoarthritis. The knee is affected more often than any other joint, ...
News Medical on MSN4d
Hydrogel-based drug delivery offers hope for post-traumatic osteoarthritisPost-traumatic osteoarthritis (PTOA) is a condition that affects joints after an injury. Current treatments focus on ...
Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...
Temporomandibular joint (TMJ) osteoarthritis is a degenerative, debilitating and progressive disease, the second most common musculoskeletal ...
Microparticle hydrogel shows clean systemic toxicity profile over 4 weeks and 13 weeks Treatment designed to restore ...
Primary total hip and total knee replacements are among the most common and successful orthopedic procedures worldwide. These ...
2025--(BUSINESS WIRE)--4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatment that ...
A new hydrogel offers sustained drug release for post-traumatic osteoarthritis, improving treatment effectiveness during joint movement.
Discover the top 10 risky factors that increase your chance of developing arthritis, from genetics to lifestyle choices, and ...
For patients that are refractory to the initial treatment plan, additional options include short term addition of amantadine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback